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ABSTRACT 
Background: Nitric oxide (NO) is a potent vasodilator that might have an 
important role in the modulation of maternal and fetal vascular tone during 
pregnancy. The effects of caffeine intake on maternal and fetal hemodynamic 
properties during pregnancy have been investigated in several human and ani- 
mal studies. However, based on a literature search, there has been no study of 
placental total nitrite (a stable product of NO) concentration (PTNC) in preg- 
nant humans or rats given caffeine. 
Objective: The aim of this study was to assess the effects of caffeine intake 
on PTNC in rats. 
Methods: This 21-day, vehicle-controlled study was conducted at the Depart- 
ment of Pharmacology, Gaziantep University Hospital, Gaziantep, Turkey. Female 
Wistar rats were randomly assigned, ~ based on age and weight, to receive 25, 50, 
or 100 mg/kg QD caffeine or 50 mg/kg QD isotonic saline solution (vehicle; age- 
matched control group), intraperitoneally for 21 days. After euthanization of 
the rats and cesarean section, the numbers of fetuses and fetal deaths were 
counted. The lengths and weights of the fetuses in each study group were 
noted. PTNC in the rats was determined using the Greiss reaction. 
Results: This study included 26 rats (7, 7, and 6 rats in the groups receiving 
25, 50, and 100 mg/kg, d caffeine, respectively; 6 rats in the control group). The 
mean (SD) lengths of the fetuses of the rats given 25, 50, and 100 mg/kg, d caffeine 
(4.90 [0.15], 4.02 [0.27], and 3.45 [0.17] mm, respectively) were significantly less 
compared with controls (5.10 [0.18] ram) (all, P < 0.001), as were the mean (SD) 
weights of the fetuses of rats given caffeine (5.86 [0.24], 4.97 [0.59], and 3.41 
[0.23] g, respectively) versus controls (6.18 [0.21] g) (all, P < 0.001). The mean 
(SD) PTNCs in rats given 25, 50, and 100 mg/kg.d caffeine (19.82 [1.97], 29.39 
[2.07], and 45.51 [7.66] nmol/g, respectively) were significantly higher compared 
with controls (16.10 [2.12] nmol/g) (all, P< 0.001). 
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Conclusions: The results of this study in rats suggest hat caffeine intake 
might increase NO production in the placenta. In addition, based on our find- 
ings and those from previous tudies, we suggest hat this increase might be 
an adaptive physiologic response to prevent undesirable ffects of caffeine 
on vascular tone during pregnancy. (Curt Ther Res Clin Exp. 2005;66:130-137) 
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INTRODUCTION 
Nitric oxide (NO) is an important mediator of many biologic functions, includ- 
ing the relaxation of smooth muscles in various tissues. 1 NO is generated from 
L-arginine by NO synthase (NOS). The 2 constitutive isoforms of NOS, endothe- 
lial (eNOS) and neuronal NOS, are calcium-calmodulin dependent, whereas the 
calcium-calmodulin-independent, inducible isoform of NOS (iNOS) is generally 
regulated at the transcriptional level in response to various stimuli. 2Although 
eNOS and iNOS are expressed in the placenta of many species, including hu- 
mans, rhesus monkeys, rats, and sheep, eNOS is the predominant NOS isoform 
in placenta. 3-6 
The L-arginine-NO system has been characterized in the fetoplacental vi lous 
tree, decidual cells, myometrial smooth-muscle cells, uterine cervix, and 
endothelium of the umbilical vein, and has been shown to be the constitutive 
calcium-calmodulin-dependent isoform/-9 The distribution of this isoform 
throughout the fetoplacental vasculature has been demonstrated on immuno- 
histochemica] nalysis. 3 
Recent studies suggest that the activity of the NO-cyclic guanosine 
monophosphate relaxation pathway is increased uring pregnancy and inhibits 
uterine contractility until term but not during delivery. 1°,:: Thus, the NO system 
might contribute to the maintenance of uterine quiescence during pregnancy 
and at the initiation of labor. 
Caffeine (1,3,7-trimethylxanthine) is present in many popular beverages, 
foods, and over-the-counter drugs. High caffeine intake (>300 mg/d) before and 
during pregnancy is reported to be associated with an increased risk for terato- 
genic effects (eg, impending abortion, premature labor, intrauterine growth 
retardation). :2 The half-life of caffeine increases from -3 hours in nonpregnant 
women to -10.5 hours during the last 4 weeks of pregnancy. In humans, this 
increase begins during the first part of pregnancy. :3 Caffeine crosses the placen- 
ta readily, and in humans, fetuses and neonates have lower levels of the 
enzymes needed to metabolize it compared with adults. 13 Thus, a given dose 
affects fetuses and neonates more than adults. In addition, increased ietary 
caffeine consumption might decrease maternal and placental blood flow and 
increase the maternal heart rate during pregnancy. 13 One study showed that the 
mean increase in maternal heart rate after drinking coffee was 8 bpm (P < 0.01), 
and the pulsatility index of the umbilical artery showed a significant increase 
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after coffee consumption (P< 0.05). 14 For these reasons, some investigators have 
recommended that pregnant women reduce their caffeine intake to -:144 mg/d. 12 
In humans, fetoplacental circulation lacks autonomic innervation, and vascular 
resistance is regulated by humoral and paracrine-autocrine m chanisms, and 
the NO radical has been shown to have a role in maintaining basal vascular 
resistance and attenuating the action of vasoconstrictors in fetoplacental circu- 
lation in vitro. 15,16 
NO is a labile molecule with a short half-life and is rapidly converted to 
nitrite and nitrate. Total serum nitrite concentration ( itrite + nitrate; a stable 
product of NO) has been suggested as an indicator of NO production in serum 
and tissues. 17 Rhodes et al is reported that in humans, the NO pathway is the 
primary source of plasma nitrite and represents 90% of NOS-derived NO. 
Based on a MEDLINE search (key terms: caffeine, placenta, and nitric oxide; 
years: 1974-2004), no study has investigated the role of caffeine in placental NO 
production in pregnant rats or pregnant humans. Thus, the aim of the present 
study was to measure the placental total nitrite concentrations (PTNCs) in pla- 
cental homogenates in pregnant rats to determine whether (1) PTNC is affect- 
ed by caffeine intake and (2) PTNC is correlated with fetal growth. 
MATERIALS AND METHODS 
This 21-day, vehicle-controlled study in rats was conducted at the Department 
of Pharmacology, Gaziantep University Hospital, Gaziantep, Turkey. Male and 
female Wistar rats aged 14 to 16 weeks were obtained from the Department of
Medical Science Application and Research Center at Gaziantep University. This 
study was approved by the ethics committee at the university. 
The rats were acclimatized to the research facility for 1 week before the 
study and received standard pellet food and water ad libitum. Animal rooms 
had a controlled temperature (22°C) and 12-hour light-dark cycle. Female rats 
were placed with a male breeder overnight. The following morning (gestational 
day [GD] 1), pregnancy was confirmed using the detection of sperm on micro- 
scopic examination of a vaginal smear. 
On GD 1, pregnant rats were randomly assigned, based on age and weight, to 
receive 25, 50, or 100 mg/kg QD caffeine or 50 mg/kg QD isotonic saline (vehi- 
cle; age-matched control group), intraperitoneally for21 days. 
On GD 21, pregnant rats were given caffeine or saline and then euthanized 
using an overdose of pentobarbital sodium. Cesarean sections were subse- 
quently performed. After cesarean section, the fetuses were euthanized using 
bleeding, and placentas were dissected from the membranes or adjacent is- 
sues. The lengths and weights of the fetuses were noted. The placentas were 
immediately frozen and stored at -80°C until analysis. Frozen tissues were 
homogenized in buffer consisting of 320 mM sucrose, 50 mM Tris-HC1, 1 mM 
EDTA, and 1 mM DL-dithiothreitol brought o pH 7.0 at 20°C with hydrochloric 
acid. The homogenate was centrifuged at 12,000g at 4°C for 20 minutes, and the 
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resulting supernatant was used for analysis. PTNC was quantified using the 
Griess reaction after incubation of supernatant with Escherichia coli nitrate 
reductase to convert nitrate to nitrite. 19 Griess reagent (1 mL 1% sulfanilamide, 
0.1% N-(1-naphthyl)ethylenediamine dihydrochloride solution, and 2.5% phos- 
phoric acid) was then added to 1 mL of supernatant. Absorbance was read at 
545 nm after 30-minute incubation (UV Mini-1240 incubator, Shimadzu Corporation, 
Kyoto, Japan). Absorbance was compared with that of standard sodium nitrite, 
which was obtained from reduction of sodium nitrate (1-100 iJmol/L). The reaction 
was linear from 0.25 to 100 pmol/L. 
Statistical Analysis 
Analysis of variance was used for data analysis. A P level <0.05 was consid- 
ered statistically significant. Statistical analysis was performed using SPSS ver- 
sion 5.0 (SPSS Inc., Chicago, Illinois). Data are presented as mean (SD). 
RESULTS 
This study included 26 rats (7, 7, and 6 rats in the groups receiving 25, 50, and 
100 mg/kg, d caffeine, respectively; 6 rats in the control group). The rats given 
caffeine showed signs of distress and irritability, including hyperactivity and 
anger, immediately after caffeine administration. Two fetuses of rats given 
100 mg/kg-d caffeine died. The mean number of fetuses in each litter was sta- 
tistically similar between the caffeine and control groups. The lengths and 
weights of the litters of the caffeine groups were significantly less compared 
with those in fetuses in the control group (all, P < 0.001) (Table). No other 
macroscopic abnormalities were found in any of the litters. 
Table. Clinical characteristics and fetal deaths in placental homogenates of rats 
receiving caffeine or isotonic saline (age-matched control group). Values are 
mean ($D) unless otherwise indicated. 
Caffeine Intake, mg/kg, d 
25 50 100 Control 
Parameter (n = 7) (n = 7) (n --- 6) (n = 6) 
Length, mm 4.90 (0.15)* 4.02 (0.27)* 3.45 (0.1 7)* 5.10 (0.18) 
Weight, g 5.86 (0.24)* 4.97 (0.59)* 3.41 (0.23)* 6.18 (0.21) 
PTNC, nmol/g tissue 19.82 (1.97)* 29.39 (2.07)* 45.51 (7.66)* 1 6.10 (2.12) 
No. of fetuses per litter 8 (3) 7 (4) 8 (2) 7 (3) 
No. of fetal deaths 0 0 2 0 
PTNC = placental total nitrite concentration. 
*P < 0.001 versus the control group. 
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The PTNCs are presented in the table and figure. The PTNCs in the groups 
receiving 25, 50, and 100 mg/kg.d caffeine (19.82 [1.97], 29.39 [2.07], and 45.51 
[7.66] nmol/g tissue, respectively) were significantly higher compared with con- 
trols (16.10 [2.12] nmol/g tissue) (all, P< 0.001). 
DISCUSSION 
Many pregnant women consume caffeine in various beverages and over-the- 
counter medications. It is widely accepted that a moderate caffeine intake 
(144-300 mg/d) is tolerated in most pregnancies; however, there are some excep- 
tions. The teratogenic effects of caffeine in pregnancy have been investigated in 
several studies in humans 2°,21 and animals. 22 Caffeine has been found to be asso- 
ciated with an increased risk for spontaneous abortion; intrauterine growth 
retardation; and intrauterine growth abnormalities, including cleft palate and 
ectrodactyly. 22 Caffeine metabolism is slower in pregnancy, particularly during 
the last trimester, when metabolism ay be only one third of normal. Caffeine 
crosses the placenta, and fetal and maternal concentrations are assumed to be 
in equilibrium. 23,24 In addition, because in humans, fetuses and neonates have 
lower levels of the enzymes needed to metabolize caffeine compared with 
adults, 13 the same caffeine dose affects fetuses and neonates more than adults. 
In the present study, the lengths and weights of the fetuses in the groups 
given caffeine were significantly ess compared with those of fetuses in the con- 
trol group (all, P< 0.001). Moreover, 2 fetuses in the group given 100 mg/kg.d 
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Figure. Mean (SD) placental total nitrite concentrations (PTNCs) in placental homo- 
genates of rats receiving caffeine or isotonic saline (age-matched control group). 
*P < 0.001 versus the control group. 
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caffeine died. Although teratogenic effects (eg, cleft palate, limb malformation, 
hematoma) ofcaffeine have been observed in several studies, 21,22 the pathogen- 
esis is unclear. 
It is well established that pregnancy is characterized by dramatic ardiovascu- 
lar adaptive responses. In particular, increased uterine blood flow has been docu- 
mented in virtually every species. 25,26 In humans, placental blood flow regulation 
is dependent on paracrine functions rather than neurologic innervation as in other 
species. 27 Experimental 6 and clinical 28 studies have shown that placental NOS activ- 
ity levels decrease as gestation progresses, uggesting that the NO system may 
contribute to the maintenance of uterine quiescence during pregnancy. Because 
NO, a potent placental vasodilator, is synthesized in the syncytiotrophoblasts, it 
might have a key role in the regulation of fetoplacental blood flow in humans. 7,29 
In humans, caffeine significantly decreases blood flow in the intervillous paces 
that compose the maternal blood compartment. Placental intervillous blood sup- 
ply has been found to decrease with maternal coffee ingestion. 3°Immunohisto- 
chemical ocalization of eNOS in the trophoblasts was found by Kay et al. 31 
Because NO is produced in these cells, which are in direct contact with maternal 
blood, reduced blood flow in this area could decrease nutrient exchange between 
the maternal and fetal blood compartments at the villous interface and decrease 
oxygen transport to the fetus, resulting in chronic fetal hypoxia, which might lead 
to intrauterine growth retardation. Also, fetoplacental hypoxia contributes to 
increased vasoconstriction, 32 resulting in increased pressure flow across vascular 
endothelium and stimulation of NO production by vascular endothelium. 33 
In the present study, the PTNCs in the groups given caffeine were significant- 
ly higher compared with those in the control group (all, P < 0.001). Based on this 
finding, it could be hypothesized that increased placental vascular esistance 
stimulates placental NOS activity and NO production. In addition, based on our 
findings, we suggest that increased NO production in the placental homogenates 
of pregnant rats given caffeine might represent an adaptive physiologic response 
to prevent undesirable ffects of caffeine on vascular tone during pregnancy. 
Another possibility is that, based on the fact that caffeine xerts everal actions 
(eg, inhibition of phosphodiesterase, mobilization of intracellular calcium, an- 
tagonism at adenosine receptors), caffeine might alter NO production in the 
placenta. 34,35 However, we cannot determine the exact action of caffeine on NO 
synthesis from this study. Further studies might provide additional information 
about he possible role of caffeine in NO production in pregnancy. 
CONCLUSIONS 
The results of this study in rats suggest hat caffeine intake might increase 
NO production in the placenta. In addition, based on our findings and those 
from previous studies, we suggest hat this increase might be an adaptive 
physiologic response to prevent undesirable effects of caffeine on vascular tone 
during pregnancy. 
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